Jupiter Research Capital (Asia) Ltd’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
Jupiter Research Capital (Asia) Ltd's CAI Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Caris Life Sciences (CAI) in Q3 2026, closing a stake of 52,754 shares — an estimated $940K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in CAI in Q2 2026 and held it in 1 quarter. The position peaked at $940K in Q2 2026. 296 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Caris Life Sciences position as of Q3 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 52,754 Caris Life Sciences shares in Q3 2026, an estimated $940K.
- Jupiter Research Capital (Asia) Ltd first reported a position in Caris Life Sciences in Q2 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Caris Life Sciences position peaked at $940K in Q2 2026.
- 296 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.